Cargando…

Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)

The therapeutic benefits of curcuminoids in various diseases have been extensively reported. However, little is known regarding their preventive effects on extensive immunosuppression. We investigated the immunoregulatory effects of a curcuminoid complex (C—S/M), solubilized with stevioside, using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sik Kim, Woo, Jeong, Seong-Hun, Shin, Ki-Won, Jin Lee, Hyeon, Park, Ji-Young, Lee, In-Chul, Jae Jeong, Hyung, Bae Ryu, Young, Kwon, Hyung-Jun, Song Lee, Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790878/
https://www.ncbi.nlm.nih.gov/pubmed/36580758
http://dx.doi.org/10.1016/j.intimp.2022.109635
_version_ 1784859274488315904
author Sik Kim, Woo
Jeong, Seong-Hun
Shin, Ki-Won
Jin Lee, Hyeon
Park, Ji-Young
Lee, In-Chul
Jae Jeong, Hyung
Bae Ryu, Young
Kwon, Hyung-Jun
Song Lee, Woo
author_facet Sik Kim, Woo
Jeong, Seong-Hun
Shin, Ki-Won
Jin Lee, Hyeon
Park, Ji-Young
Lee, In-Chul
Jae Jeong, Hyung
Bae Ryu, Young
Kwon, Hyung-Jun
Song Lee, Woo
author_sort Sik Kim, Woo
collection PubMed
description The therapeutic benefits of curcuminoids in various diseases have been extensively reported. However, little is known regarding their preventive effects on extensive immunosuppression. We investigated the immunoregulatory effects of a curcuminoid complex (C—S/M), solubilized with stevioside, using a microwave-assisted method in a cyclophosphamide (CTX)-induced immunosuppressive mouse model and identified its new pharmacological benefits. CTX-treated mice showed a decreased number of innate cells, such as dendritic cells (DCs), neutrophils, and natural killer (NK) cells, and adaptive immune cells (CD4 and CD8 T cells) in the spleen. In addition, CTX administration decreased T cell activation, especially that of Th1 and CD8 T cells, whereas it increased Th2 and regulatory T (Treg) cell activations. Pre-exposure of C—S/M to CTX-induced immunosuppressed mice restored the number of innate cells (DCs, neutrophils, and NK cells) and increased their activity (including the activity of macrophages). Exposure to C—S/M also led to the superior restoration of T cell numbers, including Th1, activated CD8 T cells, and multifunctional T cells, suppressed by CTX, along with a decrease in Th2 and Treg cells. Furthermore, CTX-injected mice pre-exposed to C—S/M were accompanied by an increase in the levels of antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase), which play an essential role against oxidative stress. Importantly, C—S/M treatment significantly reduced viral loads in severe acute respiratory syndrome coronavirus 2-infected hamsters and attenuated the gross pathology in the lungs. These results provide new insights into the immunological properties of C—S/M in preventing extensive immunosuppression and offer new therapeutic opportunities against various cancers and infectious diseases caused by viruses and intracellular bacteria.
format Online
Article
Text
id pubmed-9790878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-97908782022-12-27 Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19) Sik Kim, Woo Jeong, Seong-Hun Shin, Ki-Won Jin Lee, Hyeon Park, Ji-Young Lee, In-Chul Jae Jeong, Hyung Bae Ryu, Young Kwon, Hyung-Jun Song Lee, Woo Int Immunopharmacol Article The therapeutic benefits of curcuminoids in various diseases have been extensively reported. However, little is known regarding their preventive effects on extensive immunosuppression. We investigated the immunoregulatory effects of a curcuminoid complex (C—S/M), solubilized with stevioside, using a microwave-assisted method in a cyclophosphamide (CTX)-induced immunosuppressive mouse model and identified its new pharmacological benefits. CTX-treated mice showed a decreased number of innate cells, such as dendritic cells (DCs), neutrophils, and natural killer (NK) cells, and adaptive immune cells (CD4 and CD8 T cells) in the spleen. In addition, CTX administration decreased T cell activation, especially that of Th1 and CD8 T cells, whereas it increased Th2 and regulatory T (Treg) cell activations. Pre-exposure of C—S/M to CTX-induced immunosuppressed mice restored the number of innate cells (DCs, neutrophils, and NK cells) and increased their activity (including the activity of macrophages). Exposure to C—S/M also led to the superior restoration of T cell numbers, including Th1, activated CD8 T cells, and multifunctional T cells, suppressed by CTX, along with a decrease in Th2 and Treg cells. Furthermore, CTX-injected mice pre-exposed to C—S/M were accompanied by an increase in the levels of antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase), which play an essential role against oxidative stress. Importantly, C—S/M treatment significantly reduced viral loads in severe acute respiratory syndrome coronavirus 2-infected hamsters and attenuated the gross pathology in the lungs. These results provide new insights into the immunological properties of C—S/M in preventing extensive immunosuppression and offer new therapeutic opportunities against various cancers and infectious diseases caused by viruses and intracellular bacteria. The Authors. Published by Elsevier B.V. 2023-02 2022-12-26 /pmc/articles/PMC9790878/ /pubmed/36580758 http://dx.doi.org/10.1016/j.intimp.2022.109635 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sik Kim, Woo
Jeong, Seong-Hun
Shin, Ki-Won
Jin Lee, Hyeon
Park, Ji-Young
Lee, In-Chul
Jae Jeong, Hyung
Bae Ryu, Young
Kwon, Hyung-Jun
Song Lee, Woo
Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title_full Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title_fullStr Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title_full_unstemmed Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title_short Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)
title_sort solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: therapeutic potential against sars-cov-2 (covid-19)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790878/
https://www.ncbi.nlm.nih.gov/pubmed/36580758
http://dx.doi.org/10.1016/j.intimp.2022.109635
work_keys_str_mv AT sikkimwoo solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT jeongseonghun solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT shinkiwon solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT jinleehyeon solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT parkjiyoung solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT leeinchul solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT jaejeonghyung solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT baeryuyoung solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT kwonhyungjun solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19
AT songleewoo solubilizedcurcuminoidcomplexpreventsextensiveimmunosuppressionthroughimmunerestorationandantioxidantactivitytherapeuticpotentialagainstsarscov2covid19